EP1933869

Notkun á lL-23 og lL-17 mótlyfjum til að meðhöndla augnbólgu sjálfsofnæmissjúkdóm.

  • Status:
    EP Einkaleyfi fallið úr gildi
  • EP appl. date:
    30.8.2006
  • EP published:
    14.10.2009
  • EP application number:
    06813945.0
  • Max expiry date:
    29.8.2026
  • Expiry date:
    29.8.2013
  • Title:
    USE OF IL-23 AND IL-17 ANTAGONISTS TO TREAT AUTOIMMUNE OCULAR INFLAMMATORY DISEASE

Timeline

Today
30.8.2006EP application
14.10.2009EP Publication
19.1.2010Translation submitted
15.2.2010Registration published
29.8.2013Expires

Owner

  • Name:
    Merck Sharp & Dohme Corp., (a New Jersey corporation)
  • Address:
    126 East Lincoln Avenue, 07065, Rahway, NJ, US
  • Name:
    The Government of the United States of America as represented by The Secretary of the Department of Health and Human Services
  • Address:
    National Institutes of Health Office of Technology Transfer Suite 325, 6011 Executive Boulevard, 20852-3804, Rockville, MD, US

Inventor

  • Name:
    CUA, Daniel, J.
  • Address:
    Boulder Creek, CA, US
  • Name:
    KASTELEIN, Robert, A.
  • Address:
    Redwood City, CA, US
  • Name:
    TSAI, Van, T.
  • Address:
    San Diego, CA, US
  • Name:
    CASPI, Rachel
  • Address:
    Bethesda, MD, US
  • Name:
    SILVER, Phyllis
  • Address:
    Silver Spring, MD, US
  • Name:
    LUGER, Dror
  • Address:
    Rockville, MD, US

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113, Reykjavík,

Priority

  • Number:
    713792 P
  • Date:
    1.9.2005
  • Country:
    US
  • Number:
    837312 P
  • Date:
    11.8.2006
  • Country:
    US

Classification

  • Categories:
    A61K 39/395, A61P 27/00

Annual fees

Number

Paid

Expires

Payer

Number: 5

Paid: 21.7.2010

Expires: 31.8.2011

Payer: Örn Þór, slf.

Number: 6

Paid: 22.7.2011

Expires: 29.8.2012

Payer: Örn Þór, slf.

Number: 7

Paid: 19.7.2012

Expires: 29.8.2013

Payer: Örn Þór, slf.

Upload documents